Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bluejay Diagnostics Inc (BJDX)

Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,318
  • Shares Outstanding, K 709
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,720 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 0.72
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.23

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7000 +1.76%
on 03/09/26
3.6000 -51.94%
on 02/10/26
-1.3900 (-44.55%)
since 02/09/26
3-Month
1.7000 +1.76%
on 03/09/26
4.6800 -63.03%
on 12/10/25
-2.8700 (-62.39%)
since 12/09/25
52-Week
1.7000 +1.76%
on 03/09/26
40.8000 -95.76%
on 04/07/25
-15.0300 (-89.68%)
since 03/07/25

Most Recent Stories

More News
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook

ACTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient tests to...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

ACTON, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced that as of February 19, 2026, all of the prefunded warrants issued by the Company in its October 2025...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

ACTON, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced that it has successfully enrolled 545 patients in its SYMON™ II multicenter clinical study and has...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

ACTON, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization. Patient enrollment in SYMON-II clinical...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Raises $4M in Private Placement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Expands Partnership with SanyoSeiko

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bluejay Diagnostics...

BJDX : 1.7850 (-4.03%)
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical...

BJDX : 1.7850 (-4.03%)

Business Summary

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

See More

Key Turning Points

3rd Resistance Point 2.0333
2nd Resistance Point 1.9667
1st Resistance Point 1.9133
Last Price 1.7850
1st Support Level 1.7933
2nd Support Level 1.7267
3rd Support Level 1.6733

See More

52-Week High 40.8000
Fibonacci 61.8% 25.8638
Fibonacci 50% 21.2500
Fibonacci 38.2% 16.6362
Last Price 1.7850
52-Week Low 1.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar